SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-286369
Filing Date
2011-10-28
Accepted
2011-10-28 16:48:47
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d235704d10q.htm 10-Q 718514
2 AMENDMENT TO DEVICE DEVELOPMENT AND MANUFACTURING AGREEMENT d235704dex101.htm EX-10.1 7586
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER d235704dex311.htm EX-31.1 9951
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER d235704dex312.htm EX-31.2 9664
5 CERTIFICATIONS PURSUANT TO U.S.C. SECTION 1350 d235704dex321.htm EX-32.1 3916
  Complete submission text file 0001193125-11-286369.txt   5590403

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT amln-20110930.xml EX-101.INS 996411
7 XBRL TAXONOMY EXTENSION SCHEMA amln-20110930.xsd EX-101.SCH 57247
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amln-20110930_cal.xml EX-101.CAL 52507
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amln-20110930_def.xml EX-101.DEF 131330
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE amln-20110930_lab.xml EX-101.LAB 367033
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amln-20110930_pre.xml EX-101.PRE 272485
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19700 | Film No.: 111165728
SIC: 2834 Pharmaceutical Preparations